Kirson Eilon D. 4
4 · NovoCure Ltd · Filed Feb 26, 2019
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Kirson Eilon D.
Chief Science Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2019-02-22$53.38/sh+36,400$1,943,032→ 145,463 total - Exercise/Conversion
Restricted Stock Units
2019-02-22−36,400→ 36,399 totalExercise: $0.00From: 2019-02-22→ Ordinary Shares (36,400 underlying)
Footnotes (1)
- [F1]Fully vested as of the date hereof.